Antibiotic & Multi-Resistance: Do We Need New Antibiotics? By Marc Maury – Scientific Director, Unither Pharmaceuticals _ Full article published in Pharmanetwork: PDF file The Origins of Multi-Resistant... View Article
Advancing ophthalmology: Unither invests in its French R&D site. Unither Pharmaceuticals invests in its French R&D site to accelerate innovation in Ophthalmology Bordeaux (France), April 28, 2025 – Unither... View Article
Development of a new prophylactic vaccine ONCOVITA and UNITHER Pharmaceuticals partner to develop a new prophylactic vaccine based on Measovir® and Euroject® technologies Paris, March 13,... View Article
Successful completion of the sale of the Carragelose business Marinomed Biotech AG: Successful completion of the sale of the Carragelose business to Unither Pharmaceuticals All requirements for closing the... View Article
Rare Disease Day Rare Disease Day: A Call for Innovation in Pharmaceutical Development Marianne Henrion is R&D Site Director at Unither Pharmaceuticals since... View Article
From early stages of ophthalmic product development Unither’s CDMO supports its customers from early stages of ophthalmic product development Anaïs CASTEX holds a Master’s degree in Formulation... View Article
A Novel Approach to Dry Eye Disease Treatment Download the Whitepaper Discover a New Approach to Dry Eye Relief Dry Eye Disease (DED) affects millions of people worldwide,... View Article
Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division PRESS RELEASE Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division Required majority of shareholders vote in... View Article
